Al-Lahham A - Search Results

1

Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe.

Reinert RR, Ringelstein A, van der Linden M, Cil MY, Al-Lahham A, Schmitz FJ. Reinert RR, et al. J Clin Microbiol. 2005 Mar;43(3):1294-300. doi: 10.1128/JCM.43.3.1294-1300.2005. J Clin Microbiol. 2005. PMID: 15750098 Free PMC article.

2

In vitro activity of gatifloxacin against Streptococcus pneumoniae isolates in Germany.

Reinert RR, Al-Lahham A, Lemmen S, Lütticken R. Reinert RR, et al. J Antimicrob Chemother. 2000 Nov;46(5):854-6. doi: 10.1093/jac/46.5.854. J Antimicrob Chemother. 2000. PMID: 11062219 No abstract available.

3

In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.

Lemmen S, Al-Lahham A, Lütticken R, Reinert RR. Lemmen S, et al. Chemotherapy. 2001 Mar-Apr;47(2):104-9. doi: 10.1159/000048508. Chemotherapy. 2001. PMID: 11173811

4

Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study.

Reinert RR, Simic S, Al-Lahham A, Reinert S, Lemperle M, Lütticken R. Reinert RR, et al. J Clin Microbiol. 2001 Mar;39(3):1187-9. doi: 10.1128/JCM.39.3.1187-1189.2001. J Clin Microbiol. 2001. PMID: 11230456 Free PMC article.

5

Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials.

Reinert RR, von Eiff C, Kresken M, Brauers J, Hafner D, Al-Lahham A, Schorn H, Lütticken R, Peters G; Multicenter Study on Antibiotic Resistance in Staphylococci and other Gram-positive Cocci (MARS) Study Group. Reinert RR, et al. J Clin Microbiol. 2001 May;39(5):1928-31. doi: 10.1128/JCM.39.5.1928-1931.2001. J Clin Microbiol. 2001. PMID: 11326015 Free PMC article.

6

In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998.

Reinert RR, Al-Lahham A, Lütticken R. Reinert RR, et al. J Antimicrob Chemother. 2001 Aug;48(2):279-81. doi: 10.1093/jac/48.2.279. J Antimicrob Chemother. 2001. PMID: 11481301

7

Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany.

Reinert RR, Al-Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S, Gerards HH, Lütticken R. Reinert RR, et al. J Antimicrob Chemother. 2002 Jan;49(1):61-8. doi: 10.1093/jac/49.1.61. J Antimicrob Chemother. 2002. PMID: 11751768 Clinical Trial.

8

Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones.

Reinert RR, Al-Lahham A, Lütticken R, Boos M, Schmitz FJ. Reinert RR, et al. J Antimicrob Chemother. 2002 Jun;49(6):1015-8. doi: 10.1093/jac/dkf036. J Antimicrob Chemother. 2002. PMID: 12039895

9

Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children.

von Kries R, Hermann M, Hachmeister A, Siedler A, Schmitt HJ, Al-Lahham A, Reinert RR. von Kries R, et al. Pediatr Infect Dis J. 2002 Nov;21(11):1017-23. doi: 10.1097/00006454-200211000-00008. Pediatr Infect Dis J. 2002. PMID: 12442022

10

Will the 7-valent pneumococcal vaccine have a similar impact on all invasive pneumococcal infections in children in Germany as in the Kaiser Permanente Trial?

von Kries R, Hermann M, Al-Lahham A, Siedler A, Reinert RR. von Kries R, et al. Eur J Pediatr. 2002 Dec;161 Suppl 2:S140-3. doi: 10.1007/s00431-002-1067-9. Epub 2002 Oct 2. Eur J Pediatr. 2002. PMID: 12494261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters